{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:20:36Z","timestamp":1772259636881,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1986,6]]},"DOI":"10.1007\/bf03348098","type":"journal-article","created":{"date-parts":[[2014,4,10]],"date-time":"2014-04-10T23:56:50Z","timestamp":1397174210000},"page":"201-207","source":"Crossref","is-referenced-by-count":117,"title":["Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole"],"prefix":"10.1007","volume":"9","author":[{"given":"Enio","family":"Martino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Aghini-Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Lenziardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Baschieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. E.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pinchera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03348098_CR1","first-page":"483","volume":"22","author":"M Vastesaeger","year":"1967","unstructured":"Vastesaeger M., Gillot P., Rasson G. Etude clinique d\u2019une nouvelle medication antiangoreuse. Acta Cardiol. 22: 483, 1967.","journal-title":"Acta Cardiol."},{"key":"BF03348098_CR2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1476-5381.1970.tb09891.x","volume":"39","author":"BN Singh","year":"1970","unstructured":"Singh B.N., Vaughan Williams E.M. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br, J. Pharmacol. 39: 657, 1970.","journal-title":"Br, J. Pharmacol."},{"key":"BF03348098_CR3","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0002-9149(76)90807-9","volume":"38","author":"MB Rosenbaum","year":"1976","unstructured":"Rosenbaum M.B., Chiale P.A., Halpern M.S. Clinical efficacy of amiodarone as an antiarrythmic agent. Am. J. Cardiol. 38: 934, 1976.","journal-title":"Am. J. Cardiol."},{"key":"BF03348098_CR4","first-page":"845","volume":"69","author":"P Touboul","year":"1976","unstructured":"Touboul P., Huerta R., Porte J., Delahaye J.P. Bases electrophysiologiques de l\u2019action antiarythmique de l\u2019amiodarone chez l\u2019homme. Arch. Mal. Coeur 69: 845, 1976.","journal-title":"Arch. Mal. Coeur"},{"key":"BF03348098_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM198109033051002","volume":"305","author":"JJ Heger","year":"1981","unstructured":"Heger J.J., Prystowsky E.N., Jackman W.M., Naccarelli G.V., Warfei K.A., Rinkenberger R.L., Zipes D.P. Amiodarone: clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N. Engl. J. Med. 305: 539, 1981.","journal-title":"N. Engl. J. Med."},{"key":"BF03348098_CR6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-98-5-577","volume":"98","author":"K Nademanfee","year":"1983","unstructured":"Nademanfee K., Singh B., Hendrickson J., Intarachot V., Lopez B., Feld G., Cannon D.S., Weis J.L Amiodarone in refractory, life-threatening ventricular arrhythmias. Ann. Intern. Med. 98: 577, 1983.","journal-title":"Ann. Intern. Med."},{"key":"BF03348098_CR7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-8703(83)90002-9","volume":"106","author":"BN Singh","year":"1983","unstructured":"Singh B.N. Amiodarone: Historical development and pharmacologic profile. Am. Heart J. 106: 788, 1983.","journal-title":"Am. Heart J."},{"key":"BF03348098_CR8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/hrt.37.8.856","volume":"37","author":"DA Pritchard","year":"1975","unstructured":"Pritchard D.A., Singh B.N., Hurley P.J. Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br. Heart J. 37: 856, 1975.","journal-title":"Br. Heart J."},{"key":"BF03348098_CR9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI108466","volume":"58","author":"A Burger","year":"1976","unstructured":"Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Beraud T., Vallotton M.B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin: a drug influencing peripheral metabolism of thyroid hormones. J. Clin. Invest. 58: 255, 1976.","journal-title":"J. Clin. Invest."},{"key":"BF03348098_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2265.1978.tb03569.x","volume":"9","author":"MH Jonckheer","year":"1978","unstructured":"Jonckheer M.H., Blockx P., Broeckaert I., Cornette C., Beckers C. \u201cLow T3 syndrome\u201d in patients chronically treated with an iodine-containing drug, amiodarone. Clin. Endocrinol. (Oxf.) 9: 27, 1978.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348098_CR11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jcem-53-5-997","volume":"53","author":"S Melmed","year":"1981","unstructured":"Melmed S., Nademanee K., Reed A.W., Hendrickson J.A., Singh B.N., Hershman J.M. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J. Clin. Endocrinol. Metab. 53: 997, 1981.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348098_CR12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1210\/jcem-55-6-1058","volume":"55","author":"MJ Lambert","year":"1982","unstructured":"Lambert M.J., Burger A.G., Galeazzi R.L., Engler D. Are selective increases in serum thyroxine (T4) due to iodinated inhibitors of T4 monodeiodination indicative of hyperthyroidism. J. Clin. Endocrinol. Metab. 55: 1058, 1982.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348098_CR13","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0002-8703(83)90008-X","volume":"106","author":"BN Singh","year":"1983","unstructured":"Singh B.N., Nademanee K. Amiodarone and thyroid function: clinical implication during antiarrhythmic therapy. Am. Heart J. 106: 857, 1983.","journal-title":"Am. Heart J."},{"key":"BF03348098_CR14","unstructured":"Chevigne-Brancart M., Vandalem J.L. Thyroid function during and after amiodarone therapy. Program of the 64th Annual Meeting of the Endocrine Society, San Francisco, 1982, p. 111."},{"key":"BF03348098_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-198301000-00001","volume":"62","author":"JE Fradkin","year":"1983","unstructured":"Fradkin J.E., Woolf J. Iodine-induced thyrotoxicosis. Medicine (Baltimore) 62: 1, 1983.","journal-title":"Medicine (Baltimore)"},{"key":"BF03348098_CR16","first-page":"238","volume-title":"Colloque sur l\u2019amiodarone, Paris 1977","author":"J Baillet","year":"1977","unstructured":"Baillet J. Amiodarone et dysthyro\u00efde. In: Colloque sur l\u2019amiodarone, Paris 1977, Paris: Documentation Labaz, 1977, p. 238."},{"key":"BF03348098_CR17","first-page":"375","volume":"29","author":"MJ Bugugnani","year":"1980","unstructured":"Bugugnani M.J., Bailly M., De Soutter P., Fouye H., Haiat R. Surveillance de la fonction thyro\u00efdienne au cours des traitments prolong\u00e9s par l\u2019amiodarone. Ann. Cardiol. Angeiol. (Paris) 29: 375, 1980.","journal-title":"Ann. Cardiol. Angeiol. (Paris)"},{"key":"BF03348098_CR18","first-page":"101","volume":"28","author":"E Martino","year":"1984","unstructured":"Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pinchera A., Braverman L. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann. Intern. Med.: 28, 101, 1984.","journal-title":"Ann. Intern. Med."},{"key":"BF03348098_CR19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1210\/jcem-41-4-685","volume":"41","author":"JC Savoie","year":"1975","unstructured":"Savoie J.C., Massin J.P., Thomopoulos P., Leger F. Iodine-induced thyrotoxicosis in apparently normal thyroid gland. J. Clin. Endocrinol. Metab. 41: 685, 1975.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348098_CR20","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1136\/bmj.284.6332.1835-a","volume":"284","author":"L Wimpfheimer","year":"1982","unstructured":"Wimpfheimer L., Staubli M., Schadelin J., Studer H. Prednisone in amiodarone-induced thyrotoxicosis. Br. Med. J. 284: 1835, 1982.","journal-title":"Br. Med. J."},{"key":"BF03348098_CR21","first-page":"582","volume":"24","author":"AF Leger","year":"1983","unstructured":"Leger A.F., Fragu P., Rouger P., Laurent M.F., Tubiana M., Savoie J.C. Thyroid iodine content measured by X-Ray fluorescence in amiodarone-induced thyrotoxicosis: concise communication. J. Nucl. Med. 24: 582, 1983.","journal-title":"J. Nucl. Med."},{"key":"BF03348098_CR22","first-page":"192","volume":"28","author":"MH Jonckheer","year":"1973","unstructured":"Jonckheer M.H., Blockx P., Kaivers R., Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol. 28: 192, 1973.","journal-title":"Acta Cardiol."},{"key":"BF03348098_CR23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2362.1984.tb01212.x","volume":"14","author":"AF Leger","year":"1984","unstructured":"Leger A.F., Massin J.P., Laurent M.F., Vencens M., Auriol M., Helal O.B., Chomette G., Savoie J.C. Iodine-induced thyrotoxicosis: analysis of eighty-five consecutive cases. Eur. J. Clin. Invest. 14: 449, 1984.","journal-title":"Eur. J. Clin. Invest."},{"key":"BF03348098_CR24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/clinchem\/9.4.408","volume":"9","author":"J Benotti","year":"1963","unstructured":"Benotti J., Benotti N. Protein-bound iodine, total iodine, and butanol-extractable iodine by partial automation. Clin. Chem. 9: 408, 1963.","journal-title":"Clin. Chem."},{"key":"BF03348098_CR25","first-page":"96","volume-title":"Nonparametric Statistics for the Behavioral Sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hiil, New York, 1956, p. 96."},{"key":"BF03348098_CR26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(54)92714-2","volume":"1","author":"ME Morgans","year":"1954","unstructured":"Morgans M.E., Trotter W.R. Treatment of thyrotoxicosis with potassium perchlorate. Lancet 1: 749, 1954.","journal-title":"Lancet"},{"key":"BF03348098_CR27","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(60)90335-4","volume":"1","author":"J Crooks","year":"1960","unstructured":"Crooks J., Wayne W.E.J. A comparison of potassium perchlorate, methylthiouracil and carbimazole in the treatment of thyrotoxicosis. Lancet 1: 401, 1960.","journal-title":"Lancet"},{"key":"BF03348098_CR28","first-page":"292","volume-title":"La tiroide fisiopatologia e clinica","author":"C Cassano","year":"1964","unstructured":"Cassano C., Baschieri L. La tiroide fisiopatologia e clinica. F. Vallardi Editore, Milano 1964, p. 292."},{"key":"BF03348098_CR29","doi-asserted-by":"crossref","unstructured":"Editorial Potassium perchlorate and aplastic anemia. Br. Med. J. 1: 1520, 1961.","DOI":"10.1136\/bmj.1.5238.1520"},{"key":"BF03348098_CR30","first-page":"453","volume":"2","author":"D Barzilai","year":"1966","unstructured":"Barzilai D., Sheinfeld M. Fatal complications following use of potassium perchlorate in thyrotoxicosis. Report of two cases and a review of the literature. Isr. J. Med. Sci. 2: 453, 1966.","journal-title":"Isr. J. Med. Sci."},{"key":"BF03348098_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jcem-58-1-62","volume":"58","author":"KW Wenzel","year":"1984","unstructured":"Wenzel K.W., Lente J.R. Similar effects of thionamide drugs and perchlorate on thyroid-stimulating immunoglobulins in Graves\u2019 disease: evidence against an immunosuppressive action of thionamide drugs. J. Clin. Endocrinol. Metab. 58: 62, 1984.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348098\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T16:17:50Z","timestamp":1597681070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,6]]}},"alternative-id":["BF03348098"],"URL":"https:\/\/doi.org\/10.1007\/bf03348098","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,6]]}}}